Could an arthritis drug stop a deadly skin condition?
NCT ID NCT07708038
First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time
Summary
This trial tests whether tocilizumab, an anti-inflammatory drug, can stop the progression of calciphylaxis—a rare condition where calcium buildup blocks skin blood vessels, causing painful, non-healing wounds. Ten adults with calciphylaxis and end-stage kidney disease will receive three intravenous doses over 16 weeks. The study focuses on safety and whether the drug can reduce wound size and inflammation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tocilizumab, an anti-inflammatory drug that blocks interleukin-6 (IL-6)
- What this could lead to
- If it works, this could point toward the first FDA-approved treatment for calciphylaxis, a rare and often fatal condition with no approved therapies.
- What could go wrong
- This is a very early, small Phase 1 trial with only 10 participants, so results may not apply broadly. The drug also carries risks of serious infections and other side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CALCIPHYLAXIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could delaying kidney implant during heart transplant reduce complications?
- Dialysis duel: does higher fluid volume or lower sodium improve patient outcomes?
- New ultrasound technique spots hidden heart trouble in kids on dialysis
- Rare, deadly skin condition under the microscope: french study sheds light on calciphylaxis
- Dialysis showdown: which blood thinner works best?
- Dialysis dilemma: which access surgery is safer for seniors?